Loading...
Loading...
Among the 8 tracked institutional investors we monitor, GLUE (MONTE ROSA THERAPEUTICS INC) is held with a combined value of $301.77M across 18,496,804 shares. The largest holder is BlackRock, Inc. with a position worth $92.74M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 4 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$301.77M
Total Shares Held
18,496,804
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $92.74M | 0.00% | +34.8% |
| 2 | BAKER BROS. ADVISORS LP | $71.49M | 0.41% | - |
| 3 | STATE STREET CORP | $55.17M | 0.00% | +59.1% |
| 4 | VANGUARD GROUP INC | $50.91M | 0.00% | New |
| 5 | FMR LLC | $16.85M | 0.00% | -21.2% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $6.24M | 0.01% | New |
| 7 | CITADEL ADVISORS LLC | $5.23M | 0.00% | +276.6% |
| 8 | MILLENNIUM MANAGEMENT LLC | $3.15M | 0.00% | +84.1% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of GLUE with a position worth $92.74M, representing 0.00% of their portfolio. In total, 8 institutional investors hold GLUE with a combined value of $301.77M.
In the most recent quarter, 2 funds opened a new position in GLUE. Additionally, 4 increased their holdings and 1 reduced their positions.
Institutional investors hold $301.77M worth of GLUE stock across 8 positions. The largest institutional holder is BlackRock, Inc. with $92.74M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GLUE, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GLUE positions.